BIOG vs. APAX, IEM, RICA, SAIN, CGT, MUT, JEO, APEO, BLU, and ESCT
Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include Apax Global Alpha (APAX), Impax Environmental Markets (IEM), Ruffer Investment (RICA), Scottish American Investment (SAIN), Capital Gearing (CGT), Murray Income Trust (MUT), European Opportunities Trust (JEO), abrdn Private Equity Opportunities (APEO), Blue Star Capital (BLU), and The European Smaller Companies Trust (ESCT). These companies are all part of the "asset management" industry.
The Biotech Growth Trust vs. Its Competitors
The Biotech Growth Trust (LON:BIOG) and Apax Global Alpha (LON:APAX) are both small-cap financial services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.
The Biotech Growth Trust has higher revenue and earnings than Apax Global Alpha. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Apax Global Alpha, indicating that it is currently the more affordable of the two stocks.
The Biotech Growth Trust has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Apax Global Alpha has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500.
The Biotech Growth Trust has a net margin of 95.33% compared to Apax Global Alpha's net margin of 45.55%. The Biotech Growth Trust's return on equity of 26.96% beat Apax Global Alpha's return on equity.
28.6% of The Biotech Growth Trust shares are owned by institutional investors. Comparatively, 16.5% of Apax Global Alpha shares are owned by institutional investors. 0.7% of The Biotech Growth Trust shares are owned by insiders. Comparatively, 14.4% of Apax Global Alpha shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Apax Global Alpha had 1 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 1 mentions for Apax Global Alpha and 0 mentions for The Biotech Growth Trust. The Biotech Growth Trust's average media sentiment score of 1.87 beat Apax Global Alpha's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.
Summary
The Biotech Growth Trust beats Apax Global Alpha on 8 of the 13 factors compared between the two stocks.
Get The Biotech Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
The Biotech Growth Trust Competitors List
Related Companies and Tools
This page (LON:BIOG) was last updated on 8/8/2025 by MarketBeat.com Staff